March 16, 2012
Where are antithrombotic and anticoagulant treatments heading? Visiongain’s report shows you potential revenues to 2022, with data, forecasts and discussions.
This study assesses drugs to treat abnormal blood clotting in human beings. Discover sales predictions at world market, therapeutic class, product and national levels to 2022. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/antithrombotic-anticoagulant-drugs-world-market-2012-2022.html
How will products – Plavix, Lovenox, Pletal, Fragmin, Asasantin, Arixtra, Aspirin Cardio, Effient, Pradaxa, Brilinta and others – perform? Our report gives you business research and analysis with many sales predictions. See the future of the industry and market. Marketing Research Companies
Also, receive forecasting of submarkets, finding potential sales trends from 2012:
• Platelet aggregation inhibitors
• Vitamin K antagonists
• Direct thrombin inhibitors
• Direct factor Xa inhibitors.
Our report discusses activities of Eli Lilly, Boehringer Ingelheim, AstraZeneca, J&J, Bayer, Sanofi, Merck, Eisai, Daiichi Sankyo and other pharmaceutical companies.
What does the future hold? With its R&D pipelines, the pharma industry has potential for improved treatments and increased revenues from blood-thinning agents. Many commercial opportunities remain.
Worldwide, numbers of heart attacks and strokes will rise this decade. Blood thinners will play important roles in medicine, helping to prevent and treat cardiovascular disorders.
Visiongain’s study provides data, analysis and opinion aiming to benefit your research, calculations, meetings and presentations. You will find answers in our work.
Revenue forecasts, market shares, developmental trends, discussions and interviews
In the report you find revenue forecasting, growth rates, market shares, qualitative analyses (including SWOT and STEP), opinions and R&D news. You receive 82 tables and charts and four research interviews.
Advantages of Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 for your work
In particular, this study gives you the following knowledge and benefits:
• Find revenue predictions to 2022 for the overall world market and submarkets
• Discover revenue forecasts to 2022 for 14 drugs, assessing commercial potential
• See revenue forecasts to 2022 for leading national markets – US, Japan, Germany, France, UK, Spain, Italy, China and India
• Assess leading companies, discovering activities and outlooks
• Review R&D, seeing pipeline trends
• Investigate competition and opportunities influencing sales results
• Find out what will stimulate and restrain the industry and market
• View opinions from our survey of authorities on the sector.
For more information kindly visit :
Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Follow us on twitter: http://twitter.com/#!/Sandhya3B